相关实验视频

Updated: Jul 12, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

最近的研究和基于CTLA-4的乳腺癌免疫疗法的临床进展

Hongsheng Zhang¹, Jintao Mi¹, Qi Xin¹

¹College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Frontiers in oncology

|October 20, 2023

概括

细胞毒性T淋巴细胞相关抗原-4 (CTLA-4) 抑制剂对乳腺癌免疫疗法有希望,但治愈率仍然很低. 进一步研究组合疗法和管理与免疫相关的不良事件对于改善治疗疗效至关重要.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症研究癌症研究

背景情况:

乳腺癌存在重大治疗挑战,需要新的治疗策略.
免疫疗法,特别是免疫检查点抑制剂 (ICI),正在成为一种关键的治疗方式.
细胞毒性T淋巴细胞相关抗原-4 (CTLA-4) 抑制剂在乳腺癌中表现出进展,但治疗率有限.

研究的目的:

审查CTLA-4抑制剂单疗法和乳腺癌组合疗法的机制.
总结最近的乳腺癌基于CTLA-4的免疫疗法的临床进展.
要突出与CTLA-4抑制剂相关的免疫相关不良事件 (irAEs).

主要方法:

对CTLA-4抑制机制和临床应用的当前研究进行系统审查.
对研究CTLA-4抑制剂作为单一治疗和与其他治疗结合的研究进行分析.
检查乳腺癌患者免疫相关不良事件 (irAEs) 的数据.

主要成果:

目前正在探索CTLA-4抑制剂的各种组合,以提高疗效.
虽然取得了进展,但基于CTLA-4的疗法目前的治愈率仍不够理想.
免疫相关的不良事件 (irAEs) 是CTLA-4抑制剂治疗中的一个重要考虑因素.

结论:

进一步研究新的基于免疫的策略,包括组合疗法,对于改善乳腺癌治疗结果至关重要.
了解和管理IRE对于优化临床免疫疗法方案至关重要.
本综述提供了关于推进基于CTLA-4的乳腺癌免疫疗法的见解.

关键词:

在 CTLA-4 中.乳腺癌乳腺癌乳腺癌临床试验是指临床试验中的临床试验.免疫检查点抑制剂免疫检查点抑制剂免疫疗法免疫疗法

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...